Trent
13975  results:
Search for persons X
?
2

Architectural impacts of in-situ resource utilization produ..:

Krenn, A ; Trent, D ; Sanders, G...
IOP Conference Series: Materials Science and Engineering.  1240 (2022)  1 - p. 012010 , 2022
 
?
4

Chondrosarcoma-derived Mutation in IDH1 Promotes Tumorigene..:

Hu, X. ; Li, L. ; Trent, J..
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. S16 , 2020
 
?
5

Tumor Necrosis Following Multi-Modality Neoadjuvant Therapy..:

Seldon, C. ; Shrivastava, G.A. ; Jarboe, J.S....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e9 , 2020
 
?
6

Building the future: junior doctors as leaders:

Sharkey, A.R. ; Magee, L. ; Trent, A.
Clinical Radiology.  74 (2019)  7 - p. 492-495 , 2019
 
?
7

Pathologic Response Rates after Neoadjuvant Therapy For Sar..:

Shrivastava, G.A. ; Jarboe, J. ; Ahmed, A.A....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E803 , 2019
 
?
8

Factors Impacting Definitive Treatment Management in Adoles..:

Asher, D. ; Arora, A. ; Dooley, S....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E802 , 2019
 
?
9

Radiation Sensitization of Sarcoma by Trabectedin:

Jarboe, J. ; Zhang, S. ; Mejia, A. Paz...
International Journal of Radiation Oncology*Biology*Physics.  99 (2017)  2 - p. E598 , 2017
 
?
10

A Review of Studies on the System-Wide Implementation of Ev..:

Rosen, C. S. ; Matthieu, M. M. ; Wiltsey Stirman, S....
Administration and Policy in Mental Health and Mental Health Services Research.  43 (2016)  6 - p. 957-977 , 2016
 
?
 
?
13

Sorafenib as third- or fourth-line treatment of advanced ga..:

Montemurro, M. ; Gelderblom, H. ; Bitz, U....
European Journal of Cancer.  49 (2013)  5 - p. 1027-1031 , 2013
 
?
14

Timing of Adjuvant Chemotherapy/External Beam Radiation The..:

Mahmoud, O.M. ; Dosch, A. ; Kwon, D....
International Journal of Radiation Oncology*Biology*Physics.  87 (2013)  2 - p. S612-S613 , 2013
 
?
 
1-15